Immunodiagnostics Market Developments Shaping Growth Across The Forecast Period

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Immunodiagnostics Market From 2026 To 2030?

The immunodiagnostics market size has demonstrated significant growth over recent years. It is anticipated to expand from $24.32 billion in 2025 to $26.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. This historical expansion can be attributed to several factors, including the rising occurrence of infectious and chronic conditions, the expansion of clinical laboratory infrastructures, an increasing demand for early disease detection, the growing application of antibody-based diagnostics, and the widespread availability of standardized immunoassay technologies.

The immunodiagnostics market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $35.76 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.1%. This anticipated growth during the forecast period is primarily fueled by factors such as the greater acceptance of personalized diagnostics, increased funding for automated laboratories, the broadened reach of point-of-care immunodiagnostics, the developing integration of AI for result interpretation, and a heightened emphasis on preventive healthcare screening. Key trends expected within this timeframe involve the rising implementation of automated immunoassay analyzers, an increasing need for highly sensitive diagnostic evaluations, the expanded utilization of rapid immunodiagnostic kits, the broadening of multiplex testing capacities, and improved integration of laboratory data management systems.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

Which Factors Are Influencing The Growth Of The Immunodiagnostics Market?

The rising occurrence of chronic illnesses is anticipated to boost the expansion of the immunodiagnostics market in the foreseeable future. These are persistent health issues that typically advance gradually, including conditions like diabetes, heart disease, and arthritis, frequently demanding continuous medical care and lifestyle adjustments to manage indicators and avert adverse outcomes. The rise in chronic diseases is primarily attributed to unhealthy habits, such as inadequate nutrition, lack of physical activity, and tobacco use, all of which elevate the likelihood of developing conditions like diabetes, heart disease, and obesity. Immunodiagnostic tools assist in the diagnosis of chronic illnesses by allowing precise identification of biomarkers and immune reactions linked to enduring health problems. These tools facilitate the prompt discovery and surveillance of ailments like diabetes, autoimmune conditions, and cardiovascular issues, thereby optimizing patient care and aiding in quick treatment choices. A pertinent example is provided by the National Health Service, a UK-based government department, which reported in June 2024 that 3,615,330 people registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a state characterized by heightened blood sugar levels, insufficient for a diabetes classification) in 2023. This represented an 18% surge from 3,065,825 instances recorded in 2022. Consequently, the expanding occurrence of both chronic and infectious diseases is propelling the expansion of the immunodiagnostics market.

Which Segment Categories Are Included In The Immunodiagnostics Market Segment Analysis?

The immunodiagnostics market covered in this report is segmented –

1) By Product: Reagents And Consumables, Instruments

2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Rapid Test, Other Technologies

3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications

4) By End User: Hospitals, Clinics, Diagnostic Laboratories

Subsegments:

1) By Reagents And Consumables: Antibodies, Assay Kits, Buffers And Substrates

2) By Instruments: Immunoassay Analyzers, ELISA Readers

Which Trends Are Influencing Demand In The Immunodiagnostics Market?

Major companies engaged in the immunodiagnostics market are increasingly concentrating on developing innovative solutions, such as automated chemiluminescence immunoassays (CLIAs), to improve diagnostic accuracy, reduce testing time, and enhance laboratory efficiency. Automated chemiluminescence immunoassays (CLIAs) are laboratory tests that utilize light-emitting chemical reactions and automation to quickly and accurately detect specific proteins or antibodies in blood or other samples. For example, in September 2025, DiaSorin S.p.A., an Italy-based diagnostics company, introduced the LIAISON® TSH-R Ab assay for autoimmune thyroid disorder assessment. This test offers features like enhanced antibody specificity through its double-bridge assay architecture, seamless integration into existing LIAISON analyzers to streamline laboratory workflows, and CE-marked compatibility supporting deployment across numerous regulated regions.

Who Are The Active Companies Shaping The Immunodiagnostics Market?

Major companies operating in the immunodiagnostics market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., bioMérieux SA, Sysmex Corporation, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Fujirebio Holdings Inc., Quidel Corporation, Luminex Corporation, Bio-Techne Corporation, PerkinElmer Inc., Merck KGaA, Gold Standard Diagnostics Corp., OraSure Technologies Inc., Immunodiagnostic Systems Holdings Plc (IDS)

Get The Full Immunodiagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Where Is The Immunodiagnostics Market Most Concentrated Geographically?

North America was the largest region in the immunodiagnostics market in 2025. The regions covered in the immunodiagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Immunodiagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=10093&type=smp

Browse Through More Reports Similar to the Global Immunodiagnostics Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Automated Immunoassay Analyzers Market Report 2026

https://www.thebusinessresearchcompany.com/report/automated-immunoassay-analyzers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795